Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.3 billion.
Market Cap
1.11T
Revenue
105.3B
Profits
-41.34B
PE Ratio
n/a
Profit Margin
-39.26%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.63B | 1.14% | 729,638 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 74.82B | -1.70% | 497,607 | 14.25B |
| 3 | ARGX | argenx SE | 49.52B | -1.76% | 259,189 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 47.49B | 0.06% | 514,826 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.52B | 0.22% | 73,716 | 4.97B |
| 6 | INSM | Insmed Incorporated | 34.65B | 2.00% | 1,191,315 | 447.02M |
| 7 | BNTX | BioNTech SE | 27.19B | 2.17% | 659,935 | 3.70B |
| 8 | RVMD | Revolution Medicines, Inc. | 23.24B | -2.47% | 1,624,655 | - |
| 9 | RPRX | Royalty Pharma plc | 22.89B | -0.18% | 585,565 | 2.35B |
| 10 | INCY | Incyte Corporation | 21.19B | 2.57% | 843,309 | 4.81B |
| 11 | GMAB | Genmab A/S | 20.89B | 1.08% | 1,401,683 | 3.85B |
| 12 | MRNA | Moderna, Inc. | 16.13B | 4.88% | 8,022,565 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 15.88B | -2.02% | 2,916,049 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.81B | 0.76% | 5,338,016 | 353.78M |
| 15 | SMMT | Summit Therapeutics Inc. | 13.40B | 0.64% | 643,988 | - |
| 16 | ASND | Ascendis Pharma A/S | 12.84B | -2.70% | 461,012 | 758.59M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.16B | -2.78% | 1,378,072 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.87B | -2.97% | 1,133,053 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.44B | 1.62% | 121,173 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.93B | -0.09% | 659,141 | 20.87M |
| 21 | TECH | Bio-Techne Corporation | 10.77B | -1.18% | 1,298,766 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.57B | -0.11% | 626,694 | 3.09B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.38B | -0.24% | 527,503 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.36B | 0.80% | 451,071 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.00B | -1.13% | 731,641 | 829.45M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 8.94B | 1.88% | 318,177 | 561.26M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.74B | 5.86% | 325,104 | 7.46M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.42B | -0.35% | 349,237 | 1.24B |
| 29 | KRYS | Krystal Biotech, Inc. | 8.32B | 1.71% | 99,766 | 373.16M |
| 30 | NUVL | Nuvalent, Inc. | 8.26B | 0.15% | 102,801 | - |
| 31 | CYTK | Cytokinetics, Incorporated | 7.77B | 0.12% | 443,804 | 87.21M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.61B | -0.59% | 915,986 | 649.06M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.01B | -1.02% | 163,791 | 174.33M |
| 34 | PCVX | Vaxcyte, Inc. | 6.20B | -1.39% | 355,429 | - |
| 35 | GPCR | Structure Therapeutics Inc. | 6.19B | 5.35% | 1,003,659 | - |
| 36 | COGT | Cogent Biosciences, Inc. | 6.13B | 2.68% | 1,219,927 | - |
| 37 | PTCT | PTC Therapeutics, Inc. | 5.90B | -2.87% | 299,314 | 1.78B |
| 38 | BLTE | Belite Bio, Inc | 5.83B | 3.85% | 73,531 | - |
| 39 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.78B | -0.14% | 220,444 | 1.54M |
| 40 | KYMR | Kymera Therapeutics, Inc. | 5.68B | -0.08% | 226,103 | 43.74M |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.53B | 1.46% | 130,549 | - |
| 42 | IMVT | Immunovant, Inc. | 5.34B | 1.42% | 506,291 | - |
| 43 | IBRX | ImmunityBio, Inc. | 5.21B | 33.92% | 141,435,716 | 82.56M |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.15B | -2.76% | 262,870 | 209.22M |
| 45 | CRSP | CRISPR Therapeutics AG | 5.14B | -0.42% | 807,259 | 38.34M |
| 46 | CELC | Celcuity Inc. | 4.95B | 1.63% | 224,724 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 4.78B | 0.19% | 110,318 | 471.79M |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.61B | -2.88% | 423,957 | - |
| 49 | TGTX | TG Therapeutics, Inc. | 4.48B | -0.23% | 1,363,858 | 531.90M |
| 50 | ACAD | ACADIA Pharmaceuticals Inc. | 4.45B | -0.87% | 322,963 | 1.05B |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.43B | 0.10% | 1,905,151 | 598.70M |
| 52 | CGON | CG Oncology, Inc. | 4.40B | 2.75% | 452,360 | 2.17M |
| 53 | ADMA | ADMA Biologics, Inc. | 4.18B | 0.40% | 820,522 | 488.56M |
| 54 | LEGN | Legend Biotech Corporation | 4.11B | 0.63% | 933,000 | 909.05M |
| 55 | ACLX | Arcellx, Inc. | 4.02B | 1.87% | 230,929 | 35.90M |
| 56 | TERN | Terns Pharmaceuticals, Inc. | 4.02B | -0.05% | 1,046,288 | - |
| 57 | VKTX | Viking Therapeutics, Inc. | 3.82B | 5.93% | 2,064,319 | - |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 3.78B | -2.08% | 124,861 | 251.23M |
| 59 | CORT | Corcept Therapeutics Incorporated | 3.72B | 0.03% | 568,219 | 741.17M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.62B | 0.22% | 209,478 | 35.24M |
| 61 | LQDA | Liquidia Corporation | 3.39B | 0.41% | 1,868,288 | 69.22M |
| 62 | VERA | Vera Therapeutics, Inc. | 3.34B | 1.82% | 333,492 | - |
| 63 | CNTA | Centessa Pharmaceuticals plc | 3.32B | 1.43% | 243,451 | 15.00M |
| 64 | ARQT | Arcutis Biotherapeutics, Inc. | 3.21B | -0.57% | 444,298 | 317.93M |
| 65 | VRDN | Viridian Therapeutics, Inc. | 3.20B | 1.42% | 528,894 | 70.79M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.17B | 0.19% | 282,335 | 214.83M |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.11B | -1.10% | 409,307 | 7.50M |
| 68 | BEAM | Beam Therapeutics Inc. | 3.09B | -2.25% | 693,380 | 55.70M |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.06B | -2.01% | 393,896 | 366.10M |
| 70 | ALMS | Alumis Inc. | 3.01B | -0.04% | 947,133 | 22.12M |
| 71 | EWTX | Edgewise Therapeutics, Inc. | 2.88B | 2.41% | 637,919 | - |
| 72 | DNLI | Denali Therapeutics Inc. | 2.85B | -2.88% | 726,762 | - |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.82B | 4.38% | 692,934 | - |
| 74 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.82B | -0.22% | 357,824 | 578.20M |
| 75 | IRON | Disc Medicine, Inc. | 2.75B | 2.56% | 161,651 | - |
| 76 | RCUS | Arcus Biosciences, Inc. | 2.75B | 1.93% | 424,958 | 240.00M |
| 77 | ADPT | Adaptive Biotechnologies Corporation | 2.71B | -0.28% | 343,762 | 252.75M |
| 78 | ERAS | Erasca, Inc. | 2.67B | -1.62% | 5,647,496 | - |
| 79 | TLX | Telix Pharmaceuticals Limited | 2.61B | 4.44% | 105,553 | 664.23M |
| 80 | SYRE | Spyre Therapeutics, Inc. | 2.60B | 1.42% | 185,800 | - |
| 81 | MLYS | Mineralys Therapeutics, Inc. | 2.58B | 3.89% | 676,099 | - |
| 82 | WVE | Wave Life Sciences Ltd. | 2.58B | 0.07% | 1,383,181 | 109.23M |
| 83 | TVTX | Travere Therapeutics, Inc. | 2.55B | 0.42% | 872,273 | 435.83M |
| 84 | APLS | Apellis Pharmaceuticals, Inc. | 2.53B | -2.58% | 588,085 | 1.02B |
| 85 | OCUL | Ocular Therapeutix, Inc. | 2.53B | 5.19% | 4,052,441 | 55.78M |
| 86 | IMNM | Immunome, Inc. | 2.51B | -0.48% | 930,841 | 9.68M |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.47B | 2.16% | 13,894,569 | 43.69M |
| 88 | AAPG | Ascentage Pharma Group International | 2.46B | -1.83% | 3,835 | 54.52M |
| 89 | SLNO | Soleno Therapeutics, Inc. | 2.30B | 2.00% | 488,308 | 98.68M |
| 90 | MESO | Mesoblast Limited | 2.28B | -0.96% | 86,737 | 17.20M |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 2.24B | 0.14% | 835,466 | 2.41B |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.22B | -1.70% | 607,766 | 630.60M |
| 93 | GLPG | Galapagos NV | 2.22B | -0.82% | 81,036 | 336.64M |
| 94 | OLMA | Olema Pharmaceuticals, Inc. | 2.20B | -4.18% | 354,819 | - |
| 95 | HRMY | Harmony Biosciences Holdings, Inc. | 2.12B | 0.88% | 185,924 | 825.94M |
| 96 | ZLAB | Zai Lab Limited | 2.09B | -0.29% | 176,663 | 441.63M |
| 97 | NUVB | Nuvation Bio Inc. | 2.06B | -1.95% | 2,251,072 | 26.75M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.99B | 1.28% | 257,748 | 265.81M |
| 99 | MAZE | Maze Therapeutics, Inc. | 1.97B | 2.86% | 100,577 | 2.50M |
| 100 | VCEL | Vericel Corporation | 1.96B | 0.25% | 149,862 | 258.72M |
| 101 | NBY | NovaBay Pharmaceuticals, Inc. | 1.93B | 20.96% | 2,124,649 | 10.30M |
| 102 | NRIX | Nurix Therapeutics, Inc. | 1.92B | 0.48% | 538,487 | 83.69M |
| 103 | DNTH | Dianthus Therapeutics, Inc. | 1.90B | 0.89% | 224,815 | 3.08M |
| 104 | GLUE | Monte Rosa Therapeutics, Inc. | 1.90B | -0.21% | 383,700 | 181.54M |
| 105 | MBX | MBX Biosciences, Inc. | 1.86B | 1.17% | 250,040 | - |
| 106 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | 0.82% | 288,983 | 111.30M |
| 107 | ZYME | Zymeworks Inc. | 1.77B | -0.17% | 224,110 | 134.48M |
| 108 | SION | Sionna Therapeutics, Inc. | 1.76B | 1.65% | 112,722 | - |
| 109 | KOD | Kodiak Sciences Inc. | 1.74B | 4.87% | 433,063 | - |
| 110 | TNGX | Tango Therapeutics, Inc. | 1.73B | 9.75% | 2,602,373 | 66.50M |
| 111 | CLDX | Celldex Therapeutics, Inc. | 1.73B | 1.21% | 324,099 | 2.60M |
| 112 | BHVN | Biohaven Ltd. | 1.68B | 6.21% | 1,759,258 | - |
| 113 | UPB | Upstream Bio, Inc. | 1.68B | 0.55% | 179,657 | 2.80M |
| 114 | IMCR | Immunocore Holdings plc | 1.67B | 1.19% | 452,020 | 379.59M |
| 115 | ARDX | Ardelyx, Inc. | 1.67B | -2.27% | 2,168,916 | 398.23M |
| 116 | STOK | Stoke Therapeutics, Inc. | 1.66B | -0.55% | 654,309 | 205.63M |
| 117 | ORKA | Oruka Therapeutics, Inc. | 1.64B | 4.00% | 322,434 | - |
| 118 | PHVS | Pharvaris N.V. | 1.62B | -2.69% | 90,985 | - |
| 119 | ELVN | Enliven Therapeutics, Inc. | 1.62B | 8.38% | 698,816 | - |
| 120 | AGIO | Agios Pharmaceuticals, Inc. | 1.61B | -0.68% | 464,716 | 44.79M |
| 121 | MNKD | MannKind Corporation | 1.60B | -6.54% | 3,143,611 | 313.79M |
| 122 | FTRE | Fortrea Holdings Inc. | 1.58B | 7.46% | 1,122,906 | 2.76B |
| 123 | TYRA | Tyra Biosciences, Inc. | 1.55B | 0.34% | 189,520 | - |
| 124 | PGEN | Precigen, Inc. | 1.52B | 4.11% | 1,505,437 | 6.31M |
| 125 | INVA | Innoviva, Inc. | 1.47B | -0.25% | 159,195 | 388.52M |
| 126 | NTLA | Intellia Therapeutics, Inc. | 1.44B | 4.84% | 3,417,841 | 57.53M |
| 127 | QURE | uniQure N.V. | 1.43B | 4.69% | 830,234 | 15.75M |
| 128 | OCS | Oculis Holding AG | 1.42B | 3.36% | 113,109 | 992.00K |
| 129 | SVRA | Savara Inc. | 1.41B | -0.51% | 629,663 | - |
| 130 | TRVI | Trevi Therapeutics, Inc. | 1.40B | 1.39% | 396,186 | - |
| 131 | TSHA | Taysha Gene Therapies, Inc. | 1.34B | - | 833,512 | 6.31M |
| 132 | ATAI | AtaiBeckley Inc. | 1.33B | -1.35% | 1,212,763 | 3.02M |
| 133 | IMTX | Immatics N.V. | 1.32B | -0.81% | 180,697 | 99.45M |
| 134 | ANAB | AnaptysBio, Inc. | 1.31B | 1.97% | 132,659 | 169.47M |
| 135 | EYPT | EyePoint, Inc. | 1.30B | -0.57% | 281,299 | 42.34M |
| 136 | RAPP | Rapport Therapeutics, Inc. | 1.30B | 1.75% | 73,636 | - |
| 137 | RLAY | Relay Therapeutics, Inc. | 1.30B | -1.97% | 1,116,678 | 8.36M |
| 138 | NVAX | Novavax, Inc. | 1.29B | 1.67% | 3,138,094 | 1.06B |
| 139 | ABCL | AbCellera Biologics Inc. | 1.27B | 1.56% | 2,629,993 | 35.33M |
| 140 | PHAR | Pharming Group N.V. | 1.27B | 2.15% | 11,312 | 362.27M |
| 141 | XERS | Xeris Biopharma Holdings, Inc. | 1.26B | 2.29% | 883,139 | 266.14M |
| 142 | SANA | Sana Biotechnology, Inc. | 1.25B | 0.86% | 1,442,652 | - |
| 143 | CAPR | Capricor Therapeutics, Inc. | 1.25B | 0.83% | 422,544 | 11.13M |
| 144 | PVLA | Palvella Therapeutics, Inc. | 1.20B | -2.74% | 106,630 | - |
| 145 | MLTX | MoonLake Immunotherapeutics | 1.18B | 1.35% | 620,455 | - |
| 146 | SEPN | Septerna, Inc. | 1.18B | -3.87% | 152,427 | 22.05M |
| 147 | ORIC | ORIC Pharmaceuticals, Inc. | 1.18B | 5.03% | 809,149 | - |
| 148 | IVA | Inventiva S.A. | 1.17B | 7.37% | 223,898 | 19.93M |
| 149 | PHAT | Phathom Pharmaceuticals, Inc. | 1.11B | -5.41% | 795,292 | 147.19M |
| 150 | ZBIO | Zenas BioPharma, Inc. | 1.10B | 2.36% | 285,453 | 15.00M |
| 151 | SPRY | ARS Pharmaceuticals, Inc. | 1.07B | -2.52% | 442,782 | 142.77M |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.06B | 1.46% | 72,900 | 1.40M |
| 153 | DAWN | Day One Biopharmaceuticals, Inc. | 1.06B | -2.05% | 1,718,583 | 133.67M |
| 154 | GHRS | GH Research PLC | 1.05B | 0.21% | 76,729 | - |
| 155 | AKTS | Aktis Oncology, Inc. | 1.05B | -2.82% | 193,946 | 5.56M |
| 156 | CMPX | Compass Therapeutics, Inc. | 1.03B | 0.17% | 737,450 | 850.00K |
| 157 | NBTX | Nanobiotix S.A. | 1.03B | 0.50% | 11,362 | 11.93M |
| 158 | TBPH | Theravance Biopharma, Inc. | 1.03B | 0.85% | 111,818 | 80.33M |
| 159 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.00B | 6.37% | 924,623 | 192.44M |
| 160 | VTYX | Ventyx Biosciences, Inc. | 995.17M | 0.07% | 939,109 | - |
| 161 | RAPT | RAPT Therapeutics, Inc. | 972.37M | 9.01% | 141,894 | - |
| 162 | IOVA | Iovance Biotherapeutics, Inc. | 940.81M | 6.76% | 9,418,445 | 250.43M |
| 163 | CTMX | CytomX Therapeutics, Inc. | 940.37M | 30.59% | 7,203,753 | 113.63M |
| 164 | XNCR | Xencor, Inc. | 936.91M | -0.68% | 271,728 | 150.13M |
| 165 | BCAX | Bicara Therapeutics Inc. | 935.13M | 2.28% | 220,072 | - |
| 166 | ANNX | Annexon, Inc. | 918.18M | - | 576,445 | - |
| 167 | URGN | UroGen Pharma Ltd. | 894.28M | -2.23% | 271,215 | 96.52M |
| 168 | AVBP | ArriVent BioPharma, Inc. | 890.44M | -1.51% | 156,193 | - |
| 169 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 889.47M | -3.30% | 76,219 | - |
| 170 | DRUG | Bright Minds Biosciences Inc. | 876.65M | -1.68% | 43,305 | - |
| 171 | GERN | Geron Corporation | 861.78M | 3.85% | 8,785,731 | 183.40M |
| 172 | VALN | Valneva SE | 855.98M | 0.50% | 2,683 | 211.09M |
| 173 | VIR | Vir Biotechnology, Inc. | 854.23M | -0.97% | 724,058 | 16.86M |
| 174 | OMER | Omeros Corporation | 844.42M | -2.46% | 1,429,624 | - |
| 175 | JANX | Janux Therapeutics, Inc. | 821.02M | -0.51% | 480,422 | 10.00M |
| 176 | MDXG | MiMedx Group, Inc. | 816.04M | -4.17% | 513,855 | 393.44M |
| 177 | YDES | YD Bio Limited | 798.83M | -0.53% | 18,842 | 510.36K |
| 178 | ABUS | Arbutus Biopharma Corporation | 793.34M | -12.23% | 6,866,442 | 14.61M |
| 179 | ARVN | Arvinas, Inc. | 793.17M | 1.81% | 252,664 | 312.30M |
| 180 | NKTR | Nektar Therapeutics | 776.24M | 7.92% | 331,935 | 62.60M |
| 181 | MPLT | MapLight Therapeutics, Inc. | 768.09M | -4.76% | 90,243 | - |
| 182 | KURA | Kura Oncology, Inc. | 752.70M | -2.92% | 925,791 | 104.03M |
| 183 | KALV | KalVista Pharmaceuticals, Inc. | 752.63M | -0.47% | 258,721 | 1.43M |
| 184 | DBVT | DBV Technologies S.A. | 720.82M | 10.05% | 484,158 | 5.50M |
| 185 | PRME | Prime Medicine, Inc. | 713.46M | 1.00% | 2,278,073 | 5.98M |
| 186 | ATXS | Astria Therapeutics, Inc. | 710.71M | -2.81% | 927,549 | 706.00K |
| 187 | IVVD | Invivyd, Inc. | 703.56M | 2.25% | 870,433 | 50.04M |
| 188 | RGNX | REGENXBIO Inc. | 702.14M | 0.80% | 302,320 | 161.32M |
| 189 | GYRE | Gyre Therapeutics, Inc. | 698.95M | -0.13% | 14,833 | 107.27M |
| 190 | JBIO | Jade Biosciences, Inc. | 698.80M | 3.33% | 99,026 | - |
| 191 | SLS | SELLAS Life Sciences Group, Inc. | 694.75M | 6.25% | 4,225,031 | - |
| 192 | FULC | Fulcrum Therapeutics, Inc. | 694.67M | 1.45% | 224,726 | 80.00M |
| 193 | PROK | ProKidney Corp. | 691.92M | 5.50% | 1,001,522 | 744.00K |
| 194 | RIGL | Rigel Pharmaceuticals, Inc. | 690.48M | 0.69% | 122,603 | 282.08M |
| 195 | TENX | Tenax Therapeutics, Inc. | 654.60M | 1.48% | 76,579 | - |
| 196 | CGEM | Cullinan Therapeutics, Inc. | 647.48M | 2.81% | 279,116 | - |
| 197 | ENGN | enGene Holdings Inc. | 617.60M | - | 137,101 | - |
| 198 | MGTX | MeiraGTx Holdings plc | 612.54M | -1.04% | 330,966 | 27.42M |
| 199 | GOSS | Gossamer Bio, Inc. | 608.73M | 7.35% | 1,785,292 | 44.05M |
| 200 | VOR | Vor Biopharma Inc. | 607.52M | 11.59% | 651,506 | - |
| 201 | DRTS | Alpha Tau Medical Ltd. | 606.23M | -7.42% | 289,057 | - |
| 202 | CRVS | Corvus Pharmaceuticals, Inc. | 599.70M | 12.46% | 1,388,214 | - |
| 203 | FBRX | Forte Biosciences, Inc. | 592.54M | 1.65% | 55,585 | - |
| 204 | KROS | Keros Therapeutics, Inc. | 577.03M | -1.66% | 116,799 | 246.72M |
| 205 | REPL | Replimune Group, Inc. | 567.15M | -0.96% | 970,311 | - |
| 206 | DNA | Ginkgo Bioworks Holdings, Inc. | 566.66M | 4.07% | 550,719 | 180.61M |
| 207 | LENZ | LENZ Therapeutics, Inc. | 558.84M | -1.54% | 434,476 | 17.50M |
| 208 | LXEO | Lexeo Therapeutics, Inc. | 548.86M | 0.27% | 455,617 | - |
| 209 | EVMN | Evommune, Inc. | 547.57M | -11.38% | 99,006 | 13.00M |
| 210 | OCGN | Ocugen, Inc. | 541.88M | 7.10% | 5,990,723 | 5.37M |
| 211 | CRMD | CorMedix Inc. | 541.28M | -2.00% | 1,516,744 | 214.30M |
| 212 | DSGN | Design Therapeutics, Inc. | 541.16M | 1.50% | 148,326 | - |
| 213 | ANRO | Alto Neuroscience, Inc. | 534.96M | 1.18% | 93,443 | - |
| 214 | VSTM | Verastem, Inc. | 523.29M | 2.73% | 1,026,369 | 13.38M |
| 215 | LYEL | Lyell Immunopharma, Inc. | 522.18M | 7.20% | 101,298 | 41.00K |
| 216 | LBRX | LB Pharmaceuticals Inc | 511.93M | -5.36% | 103,011 | - |
| 217 | ZVRA | Zevra Therapeutics, Inc. | 503.86M | -0.78% | 314,722 | 84.39M |
| 218 | NAGE | Niagen Bioscience, Inc. | 503.36M | -0.40% | 300,914 | 124.71M |
| 219 | PRTA | Prothena Corporation plc | 499.00M | 0.11% | 378,977 | 11.79M |
| 220 | KYTX | Kyverna Therapeutics, Inc. | 498.17M | - | 322,397 | - |
| 221 | LXRX | Lexicon Pharmaceuticals, Inc. | 488.77M | 5.08% | 1,709,906 | 70.86M |
| 222 | MNPR | Monopar Therapeutics Inc. | 476.13M | 3.16% | 180,266 | - |
| 223 | ALT | Altimmune, Inc. | 469.37M | 1.42% | 1,443,445 | 20.00K |
| 224 | ASMB | Assembly Biosciences, Inc. | 467.40M | -1.20% | 74,347 | 37.19M |
| 225 | ABSI | Absci Corporation | 466.15M | 1.64% | 1,503,828 | 2.82M |
| 226 | VTVT | vTv Therapeutics Inc. | 459.81M | -0.52% | 9,783 | 17.00K |
| 227 | AVXL | Anavex Life Sciences Corp. | 456.57M | 5.36% | 1,077,212 | - |
| 228 | BCYC | Bicycle Therapeutics plc | 453.67M | 1.08% | 223,217 | 28.34M |
| 229 | EPRX | Eupraxia Pharmaceuticals Inc. | 452.03M | -1.37% | 41,301 | - |
| 230 | NBP | NovaBridge Biosciences | 445.60M | 5.60% | 380,272 | - |
| 231 | CTNM | Contineum Therapeutics, Inc. | 443.83M | 2.62% | 91,957 | - |
| 232 | ADCT | ADC Therapeutics SA | 440.38M | 0.14% | 343,533 | 75.21M |
| 233 | FDMT | 4D Molecular Therapeutics, Inc. | 439.94M | 1.18% | 331,107 | 120.00K |
| 234 | VNDA | Vanda Pharmaceuticals Inc. | 437.32M | -0.67% | 506,775 | 212.07M |
| 235 | PRTC | PureTech Health plc | 436.88M | 4.02% | 1,739 | 6.39M |
| 236 | IMMP | Immutep Limited | 435.08M | -3.63% | 59,765 | 3.31M |
| 237 | SLDB | Solid Biosciences Inc. | 430.06M | -2.47% | 381,995 | - |
| 238 | LCTX | Lineage Cell Therapeutics, Inc. | 415.59M | 3.94% | 926,943 | 10.82M |
| 239 | DMAC | DiaMedica Therapeutics Inc. | 415.23M | -9.25% | 342,452 | - |
| 240 | BNTC | Benitec Biopharma Inc. | 405.50M | 2.26% | 37,518 | - |
| 241 | TRDA | Entrada Therapeutics, Inc. | 400.93M | 3.33% | 141,393 | 61.52M |
| 242 | HELP | Cybin Inc. | 396.23M | 1.15% | 118,925 | - |
| 243 | RCKT | Rocket Pharmaceuticals, Inc. | 395.01M | -1.62% | 1,544,533 | - |
| 244 | AUTL | Autolus Therapeutics plc | 377.92M | -1.39% | 957,232 | 51.13M |
| 245 | ALLO | Allogene Therapeutics, Inc. | 369.68M | 2.17% | 3,362,032 | 22.00K |
| 246 | FHTX | Foghorn Therapeutics Inc. | 364.96M | -0.80% | 75,301 | 24.52M |
| 247 | NMRA | Neumora Therapeutics, Inc. | 364.52M | 0.70% | 590,015 | - |
| 248 | TECX | Tectonic Therapeutic, Inc. | 362.72M | -0.67% | 131,627 | - |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 362.23M | -5.99% | 158,633 | 65.32M |
| 250 | GLSI | Greenwich LifeSciences, Inc. | 360.50M | -4.30% | 416,235 | - |
| 251 | PEPG | PepGen Inc. | 358.18M | 4.41% | 391,698 | - |
| 252 | ACIU | AC Immune SA | 352.24M | -1.93% | 108,744 | 5.48M |
| 253 | CADL | Candel Therapeutics, Inc. | 347.51M | 6.57% | 623,092 | - |
| 254 | XOMA | XOMA Royalty Corporation | 334.47M | -6.18% | 1,018,901 | 47.11M |
| 255 | AARD | Aardvark Therapeutics, Inc. | 327.69M | -1.95% | 61,621 | - |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 327.01M | 3.31% | 140,507 | 33.98M |
| 257 | AURA | Aura Biosciences, Inc. | 325.14M | 0.20% | 76,624 | - |
| 258 | PBYI | Puma Biotechnology, Inc. | 322.50M | 0.31% | 83,247 | 212.00M |
| 259 | ZURA | Zura Bio Limited | 318.29M | 4.37% | 1,094,929 | - |
| 260 | ACHV | Achieve Life Sciences, Inc. | 308.22M | 3.58% | 778,203 | - |
| 261 | IMRX | Immuneering Corporation | 305.09M | 1.83% | 948,561 | - |
| 262 | CAMP | Camp4 Therapeutics Corporation | 301.43M | 0.52% | 53,023 | 3.80M |
| 263 | CLLS | Cellectis S.A. | 300.59M | -0.64% | 62,691 | 82.55M |
| 264 | ABEO | Abeona Therapeutics Inc. | 300.49M | 1.74% | 936,065 | 400.00K |
| 265 | STTK | Shattuck Labs, Inc. | 291.09M | 2.91% | 167,440 | 1.00M |
| 266 | ACRS | Aclaris Therapeutics, Inc. | 287.66M | -0.56% | 406,476 | 15.74M |
| 267 | AVTX | Avalo Therapeutics, Inc. | 285.10M | -1.53% | 177,807 | 192.00K |
| 268 | NGNE | Neurogene Inc. | 280.68M | 0.33% | 35,357 | 925.00K |
| 269 | ALDX | Aldeyra Therapeutics, Inc. | 279.76M | 5.44% | 801,185 | - |
| 270 | LRMR | Larimar Therapeutics, Inc. | 274.75M | -1.53% | 738,574 | - |
| 271 | HRTX | Heron Therapeutics, Inc. | 274.13M | 0.34% | 313,486 | 155.10M |
| 272 | OABI | OmniAb, Inc. | 272.80M | -1.30% | 190,713 | 21.09M |
| 273 | TARA | Protara Therapeutics, Inc. | 272.22M | 0.79% | 871,693 | - |
| 274 | GUTS | Fractyl Health, Inc. | 272.03M | 0.76% | 1,284,647 | 3.00K |
| 275 | RLMD | Relmada Therapeutics, Inc. | 271.70M | -2.50% | 263,741 | - |
| 276 | AVIR | Atea Pharmaceuticals, Inc. | 269.15M | 0.15% | 158,726 | - |
| 277 | CBIO | Crescent Biopharma, Inc. | 265.09M | 8.48% | 52,220 | - |
| 278 | FENC | Fennec Pharmaceuticals Inc. | 260.25M | 2.14% | 54,003 | 38.79M |
| 279 | RZLT | Rezolute, Inc. | 259.17M | -0.53% | 1,529,689 | - |
| 280 | IMMX | Immix Biopharma, Inc. | 255.57M | 2.97% | 455,927 | - |
| 281 | PALI | Palisade Bio, Inc. | 254.05M | -2.57% | 7,381,958 | - |
| 282 | NAUT | Nautilus Biotechnology, Inc. | 253.87M | 9.84% | 325,058 | - |
| 283 | MENS | Jyong Biotech Ltd. | 246.85M | -7.23% | 315,841 | - |
| 284 | SLN | Silence Therapeutics plc | 243.25M | -7.37% | 130,109 | 25.83M |
| 285 | OBIO | Orchestra BioMed Holdings, Inc. | 239.98M | 1.92% | 67,287 | 2.82M |
| 286 | IKT | Inhibikase Therapeutics, Inc. | 232.53M | 3.03% | 246,252 | 1.00 |
| 287 | ARMP | Armata Pharmaceuticals, Inc. | 229.36M | -1.25% | 30,043 | 5.05M |
| 288 | ENLV | Enlivex Therapeutics Ltd. | 225.51M | 1.73% | 253,995 | - |
| 289 | CCCC | C4 Therapeutics, Inc. | 220.96M | 2.70% | 793,503 | 30.11M |
| 290 | NVCT | Nuvectis Pharma, Inc. | 220.16M | 0.76% | 36,690 | - |
| 291 | HUMA | Humacyte, Inc. | 217.12M | 2.27% | 2,236,578 | 1.57M |
| 292 | VYGR | Voyager Therapeutics, Inc. | 216.28M | 1.83% | 308,774 | 31.32M |
| 293 | CABA | Cabaletta Bio, Inc. | 214.67M | 7.21% | 1,374,731 | - |
| 294 | MDWD | MediWound Ltd. | 213.22M | -4.26% | 118,144 | 20.93M |
| 295 | ALEC | Alector, Inc. | 211.75M | 6.59% | 789,977 | 69.05M |
| 296 | ARCT | Arcturus Therapeutics Holdings Inc. | 211.69M | -2.10% | 179,025 | 97.60M |
| 297 | OVID | Ovid Therapeutics Inc. | 210.25M | 1.57% | 386,109 | 6.61M |
| 298 | CGEN | Compugen Ltd. | 208.58M | 5.69% | 520,253 | 6.90M |
| 299 | TNXP | Tonix Pharmaceuticals Holding Corp. | 206.57M | 4.84% | 194,941 | 10.30M |
| 300 | MIST | Milestone Pharmaceuticals Inc. | 205.20M | -0.49% | 1,460,115 | - |
| 301 | SGMT | Sagimet Biosciences Inc. | 204.40M | 0.40% | 267,658 | - |
| 302 | CLYM | Climb Bio, Inc. | 203.87M | 13.26% | 449,539 | - |
| 303 | CRDF | Cardiff Oncology, Inc. | 202.08M | 7.53% | 487,895 | 501.00K |
| 304 | EDIT | Editas Medicine, Inc. | 199.14M | -2.39% | 1,379,488 | 46.38M |
| 305 | ZNTL | Zentalis Pharmaceuticals, Inc. | 197.81M | -3.32% | 863,083 | 26.87M |
| 306 | CHRS | Coherus Oncology, Inc. | 197.62M | -1.51% | 721,951 | 277.73M |
| 307 | QNCX | Quince Therapeutics, Inc. | 197.11M | 22.92% | 2,057,812 | - |
| 308 | GALT | Galectin Therapeutics Inc. | 196.64M | -3.17% | 352,073 | - |
| 309 | RNAC | Cartesian Therapeutics, Inc. | 193.98M | 1.36% | 82,352 | 1.09M |
| 310 | TLSA | Tiziana Life Sciences Ltd | 192.49M | 11.72% | 1,110,965 | - |
| 311 | NERV | Minerva Neurosciences, Inc. | 189.54M | 1.15% | 9,896 | - |
| 312 | SLGL | Sol-Gel Technologies Ltd. | 189.36M | -0.49% | 6,995 | 18.97M |
| 313 | SABS | SAB Biotherapeutics, Inc. | 189.00M | -0.75% | 327,857 | 114.70K |
| 314 | IPSC | Century Therapeutics, Inc. | 185.98M | -7.39% | 510,861 | 113.34M |
| 315 | KLRS | Kalaris Therapeutics, Inc. | 183.75M | 10.89% | 67,425 | - |
| 316 | PRQR | ProQR Therapeutics N.V. | 181.72M | 9.18% | 309,763 | 18.86M |
| 317 | NTHI | NeOnc Technologies Holdings, Inc. | 175.85M | 3.79% | 51,154 | 59.99K |
| 318 | SRZN | Surrozen, Inc. | 173.63M | 1.29% | 20,402 | 3.60M |
| 319 | ELDN | Eledon Pharmaceuticals, Inc. | 169.81M | 3.38% | 501,750 | - |
| 320 | RANI | Rani Therapeutics Holdings, Inc. | 168.91M | - | 658,470 | 1.20M |
| 321 | VXRT | Vaxart, Inc. | 167.99M | 7.69% | 1,024,561 | 148.20M |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 165.67M | - | 228,963 | 61.84M |
| 323 | IPHA | Innate Pharma S.A. | 161.03M | - | 40,199 | 14.84M |
| 324 | PRLD | Prelude Therapeutics Incorporated | 160.68M | -9.30% | 1,010,211 | 10.50M |
| 325 | TNYA | Tenaya Therapeutics, Inc. | 158.24M | -0.84% | 2,568,770 | - |
| 326 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 156.38M | 3.30% | 72,125 | - |
| 327 | CDXS | Codexis, Inc. | 155.81M | -3.09% | 205,053 | 52.93M |
| 328 | ELTX | Elicio Therapeutics, Inc. | 149.76M | 9.73% | 91,892 | - |
| 329 | MOLN | Molecular Partners AG | 148.66M | -1.87% | 1,293 | 856.30K |
| 330 | BDTX | Black Diamond Therapeutics, Inc. | 148.42M | -2.43% | 864,154 | 70.00M |
| 331 | IRD | Opus Genetics, Inc. | 146.89M | 2.40% | 133,575 | 14.63M |
| 332 | NKTX | Nkarta, Inc. | 144.19M | 3.57% | 481,615 | - |
| 333 | ORMP | Oramed Pharmaceuticals Inc. | 142.29M | -3.12% | 177,494 | 2.00M |
| 334 | WHWK | Whitehawk Therapeutics, Inc. | 141.39M | 7.53% | 102,727 | 14.38M |
| 335 | CRBU | Caribou Biosciences, Inc. | 141.14M | -3.21% | 1,658,574 | 9.30M |
| 336 | MCRB | Seres Therapeutics, Inc. | 140.22M | 2.11% | 16,152 | 351.00K |
| 337 | SGMO | Sangamo Therapeutics, Inc. | 139.58M | -3.53% | 4,935,355 | 32.88M |
| 338 | TTRX | Turn Therapeutics Inc. | 138.69M | -2.28% | 18,511 | - |
| 339 | FATE | Fate Therapeutics, Inc. | 136.12M | 12.38% | 3,025,066 | 7.14M |
| 340 | SPRO | Spero Therapeutics, Inc. | 135.50M | 0.21% | 155,737 | 40.55M |
| 341 | CNTX | Context Therapeutics Inc. | 135.06M | -3.29% | 688,322 | - |
| 342 | UNCY | Unicycive Therapeutics, Inc. | 132.60M | -1.59% | 393,817 | - |
| 343 | CGTX | Cognition Therapeutics, Inc. | 132.41M | 8.70% | 943,313 | - |
| 344 | ACTU | Actuate Therapeutics, Inc. | 131.79M | 6.58% | 11,891 | - |
| 345 | ACOG | Alpha Cognition Inc. | 126.00M | -0.43% | 70,949 | 7.43M |
| 346 | CNTB | Connect Biopharma Holdings Limited | 121.87M | -1.80% | 96,490 | 762.00K |
| 347 | PYXS | Pyxis Oncology, Inc. | 121.10M | 5.71% | 693,425 | 2.82M |
| 348 | GNLX | Genelux Corporation | 120.46M | 6.25% | 173,228 | 8.00K |
| 349 | KPTI | Karyopharm Therapeutics Inc. | 120.12M | -1.50% | 215,426 | 142.53M |
| 350 | AGEN | Agenus Inc. | 119.71M | -4.35% | 1,011,639 | 106.83M |
| 351 | ABOS | Acumen Pharmaceuticals, Inc. | 117.51M | 4.30% | 242,858 | - |
| 352 | STRO | Sutro Biopharma, Inc. | 117.48M | 5.51% | 46,028 | 105.65M |
| 353 | VRCA | Verrica Pharmaceuticals Inc. | 117.21M | -3.68% | 117,820 | 30.83M |
| 354 | FBIO | Fortress Biotech, Inc. | 117.01M | 8.33% | 532,103 | 62.30M |
| 355 | THAR | Tharimmune, Inc. | 111.78M | 1.01% | 188,418 | - |
| 356 | RPTX | Repare Therapeutics Inc. | 111.00M | 0.19% | 192,888 | 11.87M |
| 357 | ONCY | Oncolytics Biotech Inc. | 110.30M | 5.34% | 603,033 | - |
| 358 | MGNX | MacroGenics, Inc. | 109.44M | 1.76% | 571,937 | 127.63M |
| 359 | CBUS | Cibus, Inc. | 108.99M | 8.06% | 174,099 | 3.79M |
| 360 | ARTV | Artiva Biotherapeutics, Inc. | 108.73M | -0.67% | 94,457 | 251.00K |
| 361 | ANIX | Anixa Biosciences, Inc. | 107.80M | 0.31% | 142,185 | - |
| 362 | ETHZ | ETHZilla Corporation | 106.85M | 3.69% | 341,171 | 4.11M |
| 363 | SEER | Seer, Inc. | 106.03M | -1.31% | 94,279 | 16.38M |
| 364 | INO | Inovio Pharmaceuticals, Inc. | 105.46M | -2.85% | 733,565 | 182.34K |
| 365 | CSBR | Champions Oncology, Inc. | 101.23M | 1.64% | 148 | 58.42M |
| 366 | MREO | Mereo BioPharma Group plc | 100.54M | -5.77% | 10,436,962 | 500.00K |
| 367 | SAVA | Cassava Sciences, Inc. | 100.00M | -2.82% | 655,135 | - |
| 368 | BMEA | Biomea Fusion, Inc. | 98.63M | - | 1,199,175 | - |
| 369 | DTIL | Precision BioSciences, Inc. | 98.45M | 4.87% | 107,597 | 698.00K |
| 370 | HYFT | MindWalk Holdings Corp. | 98.05M | 5.00% | 475,194 | 19.02M |
| 371 | EXOZ | eXoZymes, Inc. | 96.45M | 6.78% | 10,766 | -700.00 |
| 372 | ADAG | Adagene Inc. | 92.38M | 2.08% | 30,227 | 103.20K |
| 373 | VANI | Vivani Medical, Inc. | 91.68M | -0.26% | 42,559 | - |
| 374 | COYA | Coya Therapeutics, Inc. | 90.39M | 7.20% | 253,197 | 3.99M |
| 375 | DWTX | Dogwood Therapeutics, Inc. | 88.23M | -1.79% | 11,962 | - |
| 376 | OKYO | OKYO Pharma Limited | 83.68M | -6.90% | 146,508 | - |
| 377 | KRRO | Korro Bio, Inc. | 83.30M | 0.51% | 56,590 | 7.37M |
| 378 | ACET | Adicet Bio, Inc. | 81.97M | 2.15% | 63,316 | - |
| 379 | ATOS | Atossa Therapeutics, Inc. | 81.51M | 8.77% | 1,299,024 | - |
| 380 | PLRX | Pliant Therapeutics, Inc. | 80.50M | 2.34% | 218,747 | - |
| 381 | SPRB | Spruce Biosciences, Inc. | 80.26M | 0.12% | 12,543 | 697.00K |
| 382 | ANVS | Annovis Bio, Inc. | 80.04M | -5.63% | 470,394 | - |
| 383 | MNOV | MediciNova, Inc. | 79.13M | 1.91% | 50,371 | 257.92K |
| 384 | KZIA | Kazia Therapeutics Limited | 78.78M | 3.14% | 124,436 | 1.20M |
| 385 | XBIT | XBiotech Inc. | 77.74M | 0.79% | 5,649 | - |
| 386 | CALC | CalciMedica, Inc. | 77.45M | 1.80% | 16,716 | - |
| 387 | COEP | Coeptis Therapeutics Holdings, Inc. | 77.14M | -0.51% | 52,637 | 501.00K |
| 388 | PTHS | Pelthos Therapeutics Inc. | 76.24M | -4.78% | 11,726 | 7.41M |
| 389 | IMUX | Immunic, Inc. | 75.78M | -1.39% | 1,114,762 | - |
| 390 | ENTX | Entera Bio Ltd. | 75.21M | 3.80% | 77,923 | 124.00K |
| 391 | PYPD | PolyPid Ltd. | 73.53M | 0.68% | 45,113 | - |
| 392 | ATYR | aTyr Pharma, Inc. | 71.19M | 2.83% | 603,554 | 190.00K |
| 393 | IMA | ImageneBio, Inc. | 70.53M | 0.64% | 5,831 | 800.00K |
| 394 | EQ | Equillium, Inc. | 70.03M | 8.49% | 310,789 | 4.39M |
| 395 | GANX | Gain Therapeutics, Inc. | 69.81M | -3.46% | 1,106,310 | - |
| 396 | IFRX | InflaRx N.V. | 69.78M | 3.00% | 348,897 | 73.73K |
| 397 | NRXP | NRx Pharmaceuticals, Inc. | 68.68M | 7.91% | 941,258 | 242.00K |
| 398 | TVGN | Tevogen Bio Holdings Inc. | 68.05M | 4.93% | 137,373 | - |
| 399 | BYSI | BeyondSpring Inc. | 67.85M | -6.78% | 9,736 | 1.88M |
| 400 | MAIA | MAIA Biotechnology, Inc. | 67.73M | 11.32% | 2,121,810 | - |
| 401 | ANL | Adlai Nortye Ltd. | 67.53M | 8.93% | 99,322 | -1.35M |
| 402 | CRVO | CervoMed Inc. | 66.62M | 1.69% | 44,439 | 6.16M |
| 403 | TCRX | TScan Therapeutics, Inc. | 66.40M | 2.63% | 271,447 | 8.42M |
| 404 | ALXO | ALX Oncology Holdings Inc. | 65.87M | 0.41% | 89,449 | - |
| 405 | MGX | Metagenomi Therapeutics, Inc. | 64.02M | 0.89% | 96,933 | 30.91M |
| 406 | ACRV | Acrivon Therapeutics, Inc. | 62.79M | 6.42% | 1,178,669 | - |
| 407 | LPCN | Lipocine Inc. | 60.96M | -2.49% | 92,410 | 4.32M |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 60.93M | 0.44% | 125,435 | - |
| 409 | RADX | Radiopharm Theranostics Limited | 59.45M | -0.19% | 14,742 | 8.20M |
| 410 | ICCC | ImmuCell Corporation | 58.98M | -1.81% | 24,291 | 27.77M |
| 411 | ATHE | Alterity Therapeutics Limited | 58.38M | 2.11% | 9,419 | 3.57M |
| 412 | GRCE | Grace Therapeutics, Inc. | 56.64M | 0.56% | 27,290 | - |
| 413 | INKT | MiNK Therapeutics, Inc. | 56.61M | 1.94% | 2,266 | - |
| 414 | PDSB | PDS Biotechnology Corporation | 54.27M | 4.98% | 237,406 | - |
| 415 | NTRB | Nutriband Inc. | 53.24M | 0.23% | 5,675 | 2.28M |
| 416 | OSTX | OS Therapies Incorporated | 52.47M | 2.05% | 270,067 | - |
| 417 | LITS | Lite Strategy, Inc. | 52.21M | 1.43% | 382,994 | - |
| 418 | IBIO | iBio, Inc. | 51.38M | 3.39% | 578,573 | 500.00K |
| 419 | ALGS | Aligos Therapeutics, Inc. | 50.95M | 0.24% | 33,094 | 2.65M |
| 420 | PSTV | Plus Therapeutics, Inc. | 50.28M | 1.83% | 13,443,867 | 5.26M |
| 421 | NRXS | NeurAxis, Inc. | 49.22M | 0.43% | 37,220 | 3.36M |
| 422 | IBO | Impact BioMedical Inc. | 48.84M | -1.71% | 15,925 | 25.00K |
| 423 | TIL | Instil Bio, Inc. | 48.69M | 0.98% | 34,245 | - |
| 424 | ABVC | ABVC BioPharma, Inc. | 48.08M | -0.49% | 34,151 | 797.92K |
| 425 | TELO | Telomir Pharmaceuticals, Inc. | 47.79M | 1.46% | 132,660 | - |
| 426 | HURA | TuHURA Biosciences, Inc. | 46.82M | 1.39% | 150,754 | - |
| 427 | NXTC | NextCure, Inc. | 45.85M | 1.63% | 28,633 | - |
| 428 | INMB | INmune Bio, Inc. | 45.75M | 5.56% | 230,258 | 50.00K |
| 429 | KZR | Kezar Life Sciences, Inc. | 45.26M | -0.32% | 8,217 | - |
| 430 | APLM | Apollomics, Inc. | 45.03M | 4.17% | 3,374 | 6.93M |
| 431 | QTTB | Q32 Bio Inc. | 43.80M | -1.11% | 57,982 | - |
| 432 | JSPR | Jasper Therapeutics, Inc. | 43.38M | 1.97% | 176,349 | - |
| 433 | XLO | Xilio Therapeutics, Inc. | 43.36M | 0.29% | 75,837 | 31.80M |
| 434 | CVM | CEL-SCI Corporation | 43.31M | 3.21% | 42,248 | - |
| 435 | ESLA | Estrella Immunopharma, Inc. | 43.30M | 6.19% | 57,672 | - |
| 436 | PASG | Passage Bio, Inc. | 43.17M | -4.90% | 17,512 | - |
| 437 | ANEB | Anebulo Pharmaceuticals, Inc. | 42.93M | 0.47% | 95,728 | - |
| 438 | TVRD | Tvardi Therapeutics, Inc. | 42.87M | 1.33% | 10,735 | - |
| 439 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 42.40M | 3.57% | 4,184,300 | - |
| 440 | GLTO | Galecto, Inc. | 41.73M | 9.23% | 11,064 | - |
| 441 | OKUR | OnKure Therapeutics, Inc. | 41.73M | 2.33% | 12,009 | - |
| 442 | VERU | Veru Inc. | 41.41M | 6.61% | 134,138 | 16.89M |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 40.87M | - | 42,088 | 90.00K |
| 444 | CING | Cingulate Inc. | 39.69M | 1.56% | 147,301 | - |
| 445 | XCUR | Exicure, Inc. | 38.82M | -2.56% | 34,397 | 500.00K |
| 446 | CELU | Celularity Inc. | 38.64M | 3.88% | 23,636 | 40.58M |
| 447 | EVAX | Evaxion A/S | 38.51M | -3.60% | 75,099 | 7.65M |
| 448 | LTRN | Lantern Pharma Inc. | 38.25M | -2.56% | 33,348 | - |
| 449 | GBIO | Generation Bio Co. | 37.93M | -0.35% | 77,966 | 15.27M |
| 450 | RNXT | RenovoRx, Inc. | 37.75M | - | 114,317 | 928.00K |
| 451 | KYNB | Kyntra Bio, Inc. | 37.54M | 2.32% | 5,355 | 8.30M |
| 452 | IOBT | IO Biotech, Inc. | 36.66M | -1.26% | 278,042 | - |
| 453 | OTLK | Outlook Therapeutics, Inc. | 35.17M | 5.06% | 1,437,227 | 1.41M |
| 454 | ANTX | AN2 Therapeutics, Inc. | 34.53M | 0.80% | 3,888 | - |
| 455 | ATRA | Atara Biotherapeutics, Inc. | 33.82M | 1.52% | 354,167 | 151.93M |
| 456 | BCTX | BriaCell Therapeutics Corp. | 32.62M | -4.68% | 588,356 | - |
| 457 | DYAI | Dyadic International, Inc. | 31.90M | -0.96% | 8,210 | 3.34M |
| 458 | SER | Serina Therapeutics, Inc. | 31.89M | 11.15% | 123,711 | 116.00K |
| 459 | SKYE | Skye Bioscience, Inc. | 31.60M | 2.41% | 131,861 | - |
| 460 | GNTA | Genenta Science S.p.A. | 31.40M | -2.90% | 52,469 | - |
| 461 | MRKR | Marker Therapeutics, Inc. | 31.18M | 6.25% | 159,268 | 4.69M |
| 462 | RNTX | Rein Therapeutics Inc. | 31.02M | 1.72% | 27,983 | - |
| 463 | BRNS | Barinthus Biotherapeutics plc | 29.81M | - | 16,659 | 14.97M |
| 464 | LIXT | Lixte Biotechnology Holdings, Inc. | 29.45M | -0.88% | 82,807 | - |
| 465 | PLUR | Pluri Inc. | 29.38M | 4.43% | 11,400 | 1.33M |
| 466 | NRSN | NeuroSense Therapeutics Ltd. | 29.27M | -0.51% | 38,210 | - |
| 467 | PTN | Palatin Technologies, Inc. | 28.83M | 9.89% | 22,291 | 8.85M |
| 468 | IGC | IGC Pharma, Inc. | 28.51M | 2.48% | 360,888 | 1.11M |
| 469 | JUNS | Jupiter Neurosciences, Inc. | 28.26M | -4.77% | 26,813 | - |
| 470 | RLYB | Rallybio Corporation | 28.09M | -1.63% | 168,928 | 674.00K |
| 471 | BOLD | Boundless Bio, Inc. | 27.94M | -0.16% | 18,892 | - |
| 472 | DARE | Daré Bioscience, Inc. | 27.88M | 0.06% | 21,600 | -57.13K |
| 473 | HYPD | Hyperion DeFi, Inc. | 27.71M | -1.49% | 131,602 | 345.32K |
| 474 | SNTI | Senti Biosciences, Inc. | 27.61M | -0.94% | 117,814 | - |
| 475 | QNTM | Quantum BioPharma Ltd. | 27.43M | 0.72% | 16,167 | - |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 26.88M | 1.43% | 570,894 | 721.00K |
| 477 | HOWL | Werewolf Therapeutics, Inc. | 26.71M | -0.10% | 377,612 | 1.14M |
| 478 | CUE | Cue Biopharma, Inc. | 26.47M | 4.73% | 501,921 | 7.10M |
| 479 | NNVC | NanoViricides, Inc. | 25.67M | 5.31% | 162,238 | - |
| 480 | PLRZ | Polyrizon Ltd. | 24.75M | -0.10% | 36,000 | - |
| 481 | KLTO | Klotho Neurosciences, Inc. | 24.23M | 5.20% | 248,495 | - |
| 482 | LONA | LeonaBio, Inc. | 24.22M | -3.08% | 61,265 | - |
| 483 | INTS | Intensity Therapeutics, Inc. | 24.09M | -4.09% | 474,619 | - |
| 484 | FBLG | FibroBiologics, Inc. | 22.73M | 1.24% | 382,051 | - |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 21.89M | -0.73% | 28,002 | 15.65M |
| 486 | LNAI | Lunai Bioworks Inc. | 21.50M | -0.17% | 52,208 | - |
| 487 | BCAB | BioAtla, Inc. | 20.89M | 10.73% | 1,362,137 | 11.00M |
| 488 | LIMN | Liminatus Pharma, Inc. | 20.81M | -1.28% | 54,103 | - |
| 489 | ALLR | Allarity Therapeutics, Inc. | 20.63M | 0.70% | 27,262 | - |
| 490 | OSRH | OSR Holdings, Inc. | 20.54M | 2.33% | 663,615 | -90.52K |
| 491 | KTTA | Pasithea Therapeutics Corp. | 20.32M | -1.02% | 33,267 | - |
| 492 | CASI | CASI Pharmaceuticals, Inc. | 19.84M | -7.16% | 20,721 | 26.85M |
| 493 | KALA | KALA BIO, Inc. | 19.77M | 16.53% | 3,090,160 | - |
| 494 | LSTA | Lisata Therapeutics, Inc. | 19.41M | 0.92% | 20,566 | 1.07M |
| 495 | CLGN | CollPlant Biotechnologies Ltd. | 19.16M | -4.46% | 5,640 | 2.48M |
| 496 | VYNE | VYNE Therapeutics Inc. | 19.04M | 0.86% | 162,802 | 524.00K |
| 497 | CVKD | Cadrenal Therapeutics, Inc. | 18.85M | -1.71% | 14,152 | - |
| 498 | KAPA | Kairos Pharma, Ltd. | 18.32M | -1.12% | 30,253 | - |
| 499 | PMN | ProMIS Neurosciences, Inc. | 17.87M | 1.79% | 8,666 | - |
| 500 | ITRM | Iterum Therapeutics plc | 17.72M | 4.16% | 226,155 | 390.00K |
| 501 | LEXX | Lexaria Bioscience Corp. | 17.69M | -2.72% | 47,042 | 522.00K |
| 502 | CTXR | Citius Pharmaceuticals, Inc. | 17.66M | -0.71% | 169,971 | - |
| 503 | HOTH | Hoth Therapeutics, Inc. | 16.45M | -1.85% | 207,125 | - |
| 504 | CLRB | Cellectar Biosciences, Inc. | 15.51M | 0.20% | 25,436 | - |
| 505 | COCP | Cocrystal Pharma, Inc. | 15.37M | 0.45% | 21,820 | - |
| 506 | APLT | Applied Therapeutics, Inc. | 15.32M | -1.37% | 7,729,985 | 1.00M |
| 507 | BCDA | BioCardia, Inc. | 14.75M | -0.71% | 32,959 | 3.00K |
| 508 | TRAW | Traws Pharma, Inc. | 14.30M | 4.07% | 503,291 | 2.85M |
| 509 | SNGX | Soligenix, Inc. | 14.22M | 5.23% | 97,965 | 2.34K |
| 510 | NCNA | NuCana plc | 14.07M | 1.20% | 133,436 | - |
| 511 | SNSE | Sensei Biotherapeutics, Inc. | 13.71M | -6.37% | 53,403 | - |
| 512 | AEON | AEON Biopharma, Inc. | 13.38M | -1.74% | 38,025 | - |
| 513 | SYBX | Synlogic, Inc. | 13.34M | - | 1,097 | 8.00K |
| 514 | TPST | Tempest Therapeutics, Inc. | 13.30M | 1.89% | 42,257 | - |
| 515 | MBRX | Moleculin Biotech, Inc. | 12.66M | -3.75% | 73,114 | - |
| 516 | GRDX | GridAI Technologies Corp. | 12.64M | -5.05% | 90,929 | - |
| 517 | AKTX | Akari Therapeutics, Plc | 12.60M | 2.99% | 216,994 | - |
| 518 | CRIS | Curis, Inc. | 12.54M | 2.14% | 447,654 | 11.65M |
| 519 | BOLT | Bolt Biotherapeutics, Inc. | 12.47M | -6.92% | 27,829 | 5.20M |
| 520 | BLRX | BioLineRx Ltd. | 12.46M | -1.39% | 41,407 | 12.74M |
| 521 | PHIO | Phio Pharmaceuticals Corp. | 12.28M | 0.94% | 86,268 | - |
| 522 | INAB | IN8bio, Inc. | 12.19M | 13.36% | 175,848 | - |
| 523 | LGVN | Longeveron Inc. | 12.04M | 0.07% | 42,739 | 1.44M |
| 524 | EDSA | Edesa Biotech, Inc. | 11.92M | 0.70% | 7,835 | - |
| 525 | IMNN | Imunon, Inc. | 11.90M | 0.86% | 15,541 | - |
| 526 | GDTC | CytoMed Therapeutics Limited | 10.85M | 1.08% | 47,511 | 573.19K |
| 527 | NCEL | NewcelX Ltd. | 10.76M | -3.28% | 52,411 | - |
| 528 | CMMB | Chemomab Therapeutics Ltd. | 10.63M | 1.62% | 32,671 | - |
| 529 | BRTX | BioRestorative Therapies, Inc. | 10.08M | 2.32% | 14,088 | 383.40K |
| 530 | ABP | Abpro Holdings, Inc. | 9.48M | -1.97% | 5,851 | 183.00K |
| 531 | PULM | Pulmatrix, Inc. | 9.43M | 2.06% | 14,666 | 3.00K |
| 532 | ERNA | Ernexa Therapeutics Inc. | 9.34M | 0.85% | 24,340 | 1,000.00 |
| 533 | APVO | Aptevo Therapeutics Inc. | 9.30M | 3.19% | 53,725 | - |
| 534 | EVGN | Evogene Ltd. | 9.29M | 2.86% | 10,753 | 8.02M |
| 535 | BIVI | BioVie Inc. | 9.20M | 3.39% | 40,111 | - |
| 536 | ICU | SeaStar Medical Holding Corporation | 9.19M | -0.78% | 38,799 | 881.00K |
| 537 | PMCB | PharmaCyte Biotech, Inc. | 9.14M | -3.65% | 126,397 | - |
| 538 | IMRN | Immuron Limited | 8.95M | -0.93% | 39,673 | 4.78M |
| 539 | QNRX | Quoin Pharmaceuticals, Ltd. | 8.81M | -1.50% | 21,920 | - |
| 540 | ALZN | Alzamend Neuro, Inc. | 8.80M | 2.89% | 67,934 | - |
| 541 | APM | Aptorum Group Limited | 8.55M | - | 11,030 | - |
| 542 | XTLB | XTL Biopharmaceuticals Ltd. | 8.43M | 2.46% | 228,693 | 968.00K |
| 543 | RNAZ | TransCode Therapeutics, Inc. | 8.13M | 0.45% | 4,720 | - |
| 544 | KPRX | Kiora Pharmaceuticals, Inc. | 8.03M | - | 1,059 | 20.00K |
| 545 | ADXN | Addex Therapeutics Ltd | 7.99M | 2.84% | 4,393 | 198.82K |
| 546 | PCSA | Processa Pharmaceuticals, Inc. | 7.93M | -5.66% | 56,923 | - |
| 547 | GTBP | GT Biopharma, Inc. | 7.92M | 2.05% | 1,064,473 | - |
| 548 | BGMS | Bio Green Med Solution, Inc. | 7.84M | 11.89% | 43,593 | 81.00K |
| 549 | MBIO | Mustang Bio, Inc. | 7.81M | 1.90% | 8,141 | - |
| 550 | CLDI | Calidi Biotherapeutics, Inc. | 7.61M | - | 76,578 | - |
| 551 | SLXN | Silexion Therapeutics Corp | 7.38M | -3.28% | 30,666 | - |
| 552 | TOVX | Theriva Biologics, Inc. | 7.09M | -4.05% | 2,769,305 | - |
| 553 | GNPX | Genprex, Inc. | 7.07M | -7.58% | 1,439,735 | - |
| 554 | CELZ | Creative Medical Technology Holdings, Inc. | 7.01M | 5.53% | 38,434 | 6.00K |
| 555 | MTVA | MetaVia Inc. | 6.74M | -7.27% | 390,748 | - |
| 556 | TCRT | Alaunos Therapeutics, Inc. | 6.63M | 5.69% | 6,173 | 6.00K |
| 557 | PPBT | Purple Biotech Ltd | 6.50M | -3.03% | 46,777 | - |
| 558 | JAGX | Jaguar Health, Inc. | 6.37M | 83.78% | 132,337,063 | 11.79M |
| 559 | ADIL | Adial Pharmaceuticals, Inc. | 6.34M | 0.48% | 127,010 | - |
| 560 | ACXP | Acurx Pharmaceuticals, Inc. | 6.30M | -0.19% | 10,259 | - |
| 561 | APRE | Aprea Therapeutics, Inc. | 6.29M | 0.68% | 38,945 | 488.24K |
| 562 | INDP | Indaptus Therapeutics, Inc. | 6.22M | 17.55% | 167,844 | - |
| 563 | DCOY | Decoy Therapeutics Inc. | 5.99M | -2.50% | 317,141 | - |
| 564 | CANF | Can-Fite BioPharma Ltd. | 5.69M | -7.24% | 49,765 | 560.00K |
| 565 | XBIO | Xenetic Biosciences, Inc. | 5.59M | 7.06% | 45,480 | 2.86M |
| 566 | REVB | Revelation Biosciences, Inc. | 5.47M | 2.51% | 15,137 | - |
| 567 | GOVX | GeoVax Labs, Inc. | 5.38M | 9.82% | 130,787 | 3.35M |
| 568 | CYCN | Cyclerion Therapeutics, Inc. | 5.37M | 3.68% | 49,764 | 2.86M |
| 569 | VIVS | VivoSim Labs, Inc. | 5.35M | 1.98% | 25,903 | 140.00K |
| 570 | ASBP | Aspire Biopharma Holdings, Inc. | 5.32M | -4.62% | 772,479 | 1.94K |
| 571 | SILO | Silo Pharma, Inc. | 4.99M | -1.78% | 87,969 | 72.10K |
| 572 | CNSP | CNS Pharmaceuticals, Inc. | 4.50M | -1.56% | 44,060 | - |
| 573 | PPCB | Propanc Biopharma, Inc. | 4.48M | -4.64% | 110,140 | - |
| 574 | MTNB | Matinas BioPharma Holdings, Inc. | 4.45M | -0.86% | 14,266 | - |
| 575 | GLMD | Galmed Pharmaceuticals Ltd. | 4.28M | -0.32% | 67,171 | - |
| 576 | ENVB | Enveric Biosciences, Inc. | 4.06M | -2.70% | 22,073 | - |
| 577 | PHGE | BiomX Inc. | 4.02M | 0.77% | 12,890 | - |
| 578 | XRTX | XORTX Therapeutics Inc. | 3.91M | 0.87% | 12,578 | - |
| 579 | OGEN | Oragenics, Inc. | 3.79M | -2.90% | 18,521 | - |
| 580 | CMND | Clearmind Medicine Inc. | 3.75M | -5.04% | 38,994 | - |
| 581 | AZTR | Azitra, Inc. | 3.64M | -1.63% | 3,366,757 | 7.50K |
| 582 | HCWB | HCW Biologics Inc. | 3.58M | 16.23% | 186,085 | 422.03K |
| 583 | ARTL | Artelo Biosciences, Inc. | 3.51M | 4.61% | 81,487 | - |
| 584 | SPRC | SciSparc Ltd. | 3.51M | 1.90% | 269,569 | 1.31M |
| 585 | LYRA | Lyra Therapeutics, Inc. | 3.50M | 1.52% | 32,460 | 600.00K |
| 586 | BBLG | Bone Biologics Corporation | 3.32M | 10.78% | 92,317 | - |
| 587 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.31M | 2.84% | 62,127 | 15.78K |
| 588 | GRI | GRI Bio, Inc. | 3.17M | -5.54% | 841,687 | - |
| 589 | SCNI | Scinai Immunotherapeutics Ltd. | 3.15M | -0.01% | 14,876 | 1.15M |
| 590 | ENSC | Ensysce Biosciences, Inc. | 3.07M | -6.22% | 45,777 | 4.49M |
| 591 | DRMA | Dermata Therapeutics, Inc. | 2.77M | 4.89% | 400,788 | - |
| 592 | ONCO | Onconetix, Inc. | 2.57M | 2.48% | 10,698 | 1.22M |
| 593 | CDT | CDT Equity Inc. | 2.42M | 2.98% | 29,402 | - |
| 594 | VRAX | Virax Biolabs Group Limited | 2.38M | 1.91% | 180,151 | 2.99K |
| 595 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.33M | 18.13% | 2,521,616 | 1.36M |
| 596 | BDRX | Biodexa Pharmaceuticals Plc | 1.90M | 4.15% | 1,060,455 | 104.90K |
| 597 | ADTX | Aditxt, Inc. | 1.50M | 13.96% | 3,672,013 | 5.95K |
| 598 | MLEC | Moolec Science SA | 1.33M | -35.32% | 474,453 | 7.83M |
| 599 | PBM | Psyence Biomedical Ltd. | 1.17M | -6.57% | 316,129 | - |
| 600 | ELAB | PMGC Holdings Inc. | 630.64K | -8.63% | 220,474 | 285.95K |